absorption

(redirected from Therapeutic drug monitoring)
Also found in: Dictionary, Thesaurus, Medical, Legal, Acronyms, Encyclopedia, Wikipedia.

Absorption

1. The total demand for all goods and services in an economy. One calculates the absorption by adding the value of all goods and services produced and consumed locally to that of all imports.

2. A French term for acquisition.

absorption

the sharing of indirect costs or OVERHEADS to units of product by means of COST RATES. Provided that actual overheads do not exceed BUDGET and that actual output is the same as budgeted output, then the overhead cost rate should allow total product cost to be determined, and a selling price set which will recover the overhead costs involved in producing and selling the product. See STANDARD COST, OVERHEAD COST VARIANCE.
References in periodicals archive ?
The contribution of a simple bioassay in effective therapeutic drug monitoring of posaconazole and voriconazole.
The approach is already being investigated for drugs-of-abuse screening and therapeutic drug monitoring. (6) In addition, use of alternate matrices such as hair and oral fluid are gaining popularity in the clinical lab.
Under this collaboration, Theradiag will grant MLS an exclusive know-how license for the validation, commercialisation and promotion in the US of therapeutic drug monitoring assays.
Determination of rifampicin in human plasma and blood spots by high performance liquid chromatography with UV detection: A potential method for therapeutic drug monitoring. Journal of Pharmaceutical and Biomedical Analysis, 44: 963-969.
Despite the lack of clear explanation for the lower etanercept levels in some of the patients in the absence of immunogenicity, this study demonstrates that therapeutic drug monitoring should not be limited only to those agents having a potential to develop anti-drug antibodies.
Therefore it is necessary the therapeutic drug monitoring in the patient's bloodstream.
However, further research of therapeutic drug monitoring needs to be done to fully understand appropriate application and interpretation of therapeutic drug monitoring in tuberculosis patients, as illustrated by this case cluster.
It will focus on biomarker discovery and quantification, disease mechanisms, therapeutic drug monitoring, and disease pathophysiology.
The 21 chapters presented by the authors (of Royal Infirmary of Edinburgh and the Western General Hospital in Edinburgh, Scotland) first cover requesting and interpreting tests; disturbances of water, sodium, and potassium balance; and acid-base balance and oxygen transport and are thereafter organized by disease category, with the exception of the two final chapters on therapeutic drug monitoring and chemical toxicology and clinical biochemistry in pediatrics and geriatrics.

Full browser ?